|
|
|
Insider
Information: |
Gold Mitchell |
Relationship: |
Executive Chairman and... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
457,263 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
457,263 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-12 |
4 |
AS |
$17.32 |
$711,026 |
D/D |
(41,063) |
0 |
0 |
% |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-19 |
4 |
AS |
$20.01 |
$48,064 |
D/D |
(2,402) |
0 |
0 |
% |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-22 |
4 |
AS |
$20.43 |
$772,595 |
D/D |
(37,825) |
0 |
0 |
% |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-26 |
4 |
AS |
$20.22 |
$495,217 |
D/D |
(24,486) |
0 |
0 |
% |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-27 |
4 |
AS |
$20.04 |
$592,717 |
D/D |
(29,573) |
0 |
0 |
% |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-28 |
4 |
AS |
$20.04 |
$20,362 |
D/D |
(1,016) |
0 |
0 |
% |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2024-05-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,627,157) |
0 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2024-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(109,245) |
0 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-28 |
4 |
OE |
$0.65 |
$660 |
D/D |
1,016 |
1,016 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2019-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-19 |
4 |
OE |
$0.45 |
$1,081 |
D/D |
2,402 |
2,402 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2019-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
6,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-12 |
4 |
OE |
$0.45 |
$3,876 |
D/D |
8,613 |
8,613 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2018-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
11,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2018-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
17,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2018-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
20,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2017-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
23,292 |
23,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-26 |
4 |
OE |
$0.45 |
$15,436 |
D/D |
24,486 |
24,486 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-27 |
4 |
OE |
$0.65 |
$19,222 |
D/D |
29,573 |
29,573 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-11 |
4 |
AS |
$17.26 |
$1,189,027 |
D/D |
(68,870) |
32,450 |
0 |
% |
|
DNDN |
Dendreon Corp |
CEO |
|
2003-09-03 |
4 |
A |
$6.32 |
$221,200 |
D/D |
35,000 |
35,000 |
|
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-22 |
4 |
OE |
$0.45 |
$17,021 |
D/D |
37,825 |
37,825 |
0 |
- |
|
DNDN |
Dendreon Corp |
CEO |
|
2003-09-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
35,000 |
39,990 |
|
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2005-01-31 |
5 |
S |
$5.78 |
$8,849 |
D/D |
(1,531) |
46,511 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2005-03-18 |
4 |
B |
$5.64 |
$22,540 |
D/D |
4,000 |
50,511 |
2.74 |
- |
|
140 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|